Malignant germ cell tumours in childhood

European Journal of Cancer Part A

Volumn 33, Issue 6, 1997, Pages 895-901

  Pinkerton, C R ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CARBOPLATIN; CISPLATIN; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; VINCRISTINE;

ANEUPLOIDY; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CHILDHOOD CANCER; CHROMOSOME 12P; CYTOGENETICS; EMBRYO DEVELOPMENT; GERM CELL; GERM CELL TUMOR; ISOCHROMOSOME; MEDIASTINUM TUMOR; OVARY TUMOR; PLOIDY; PRIORITY JOURNAL; REVIEW; SACROCOCCYX TUMOR; TERATOMA; TESTIS TUMOR;

EID: 0030799621     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)00157-3     Document Type: Article

References (51)

1. Williams SD, Birch R, Einhorn L, et al. Treatment of disseminated germ cell tumors with cisplatin, bleomycin and either vinblastine or etoposide. N Engl J Med 1987, 316, 1435-1440.
2. Pinkerton CR, Pritchard J, Spitz L. High complete response rate in children with advanced germ cell tumours using cisplatin-containing combination chemotherapy. J Clin Oncol 1986, 4, 194-199.
3. Hawkins EP, Perlman EJ. Germ cell tumors. In Parnham DM, ed. Pediatric Neoplasia. Philadelphia, Lippincott-Raven, 1996, 297-330.
4. Variend S. Germ cell tumors. Current Histopathology, Paediatric Neoplasia, London, Kluwer Academic Publishers, 1993, 70-80.
5. Corbett R, Carter R, MacVicar D, Horwich A, Pinkerton CR. Embryonal rhabdomyosarcoma arising in a germ cell tumour. Proceedings of the Tumour Board of the Royal Marsden Hospital, Sutton, Surrey. Med Pediatr Oncol 1994, 23, 497-502.
6. Bosl GJ, Dmitrovsky E, Reuter VE, et al. Isochromosome of chromosome 12: clinically useful marker for male germ cell tumors. J Natl Cancer Inst 1989, 81, 1874-1878.
7. Rodriquez E, Mathew S, Mukherjee AB, Reuter VE, Bosl GJ, Chaganti RS. Analysis of chromosome 12 aneuploidy in interphase cells from human male germ cell tumors by fluorescence in situ hybridization. Genes Chromosomes Cancer 1992, 5, 21-29.
8. Atkin XB, Baker MC. Abnormal chromosomes including small metacentrics in 14 ovarian cancers. Cancer Genet Cytogenet 1987, 26, 355-361.
9. Hoffner L, Deka R, Chakravarti A, Surti U. Cytogenetics and origins of pediatric germ cell tumors. Cancer Genet Cytogenet 1994, 74, 54-58.
10. Jenderny J, Koster E, Borchers O, et al. Interphase cytogenetics on paraffin sections of paediatric extragonadal yolk sac tumours. Virchows Archiv 1996, 428, 53-57.
11. Perlman EJ, Cushing B, Hawkins E, Griffin CA. Cytogenetic analysis of childhood endodermal sinus tumours: a Pediatric Oncology Group study. Pediatr Pathol 1994, 14, 695-708.
12. Ladanyi M, Samaniego F, Reuter VE, et al. Cytogenetic and immunohistochemical evidence for the germ cell origin of a subset of acute leukemias associated with mediastinal germ cell tumors. J Natl Cancer Inst 1990, 82, 221.
13. Silver SA, Wiley JM, Perlman EJ. DNA ploidy analysis of pediatric germ cell tumors. Mod Pathol 1994, 7, 951-956.
14. Perlman EJ, Valentine MB, Griffin CA, Look AT. Deletion of Ip36 in childhood endodermal sinus tumors by two-color fluorescence in situ hybridization: a Pediatric Oncology Group study. Genes Chromosomes Cancer 1996, 16, 15-20.
15. Mead GM, Stenning SP, Parkinson MC, et al. The second Medical Research Council study of prognostic factors in nonseminomatous germ cell tumors. J Clin Oncol 1992, 10, 85-94.
16. Gerl A, Clemm C, Schmeller N, Hartenstein R, Lamerz R, Wilmanns W. Advances in the management of metastatic nonseminomatous germ cell tumours during the cisplatin era: a single-institution experience. Br J Cancer 1996, 74, 1280-1285.
17. Truong LD, Harris L, Mattioli C, et al. Endodermal sinus tumor of the mediastinum. Cancer 1986, 58, 730-739.
18. Orr PS, Gibson A, Young OG. Ovarian tumors in children: a 27 year review. Br J Surg 1986, 132, 587-589.
19. Huddart SN, Mann JR, Gornall P, et al. The UK Children's Cancer Study Group: testicular malignant germ cell tumours 1979-1988. J Pediatr Surg 1990, 25, 406-410.
20. Visfeldt J, Jorgensen N, Muller J, Moller H, Skakkebaek NE. Testicular germ cell tumours of childhood in Denmark, 1943-1989: incidence and evaluation of histology using immunohistochemical techniques. J Pathol 1994, 174, 39-47.
21. Toner GC, Panicek DM, Heelan RT, et al. Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: recommendations for patient selection. J Clin Oncol 1990, 8, 1683-1694.
22. Einhorn LH. Do all germ cell tumor patients with residual masses in multiple sites require postchemotherapy resections? J Clin Oncol 1997, 15, 409.
23. Flamant F, Schwartz L, Delons E, et al. Nonseminomatous malignant germ cell tumors in children. Multidrug therapy in stages III and IV. Cancer 1984, 54, 1687-1691.
24. Boyer M, Raghavan D, Harris PJ, et al. Lack of late toxicity in patients treated with cisplatin-containing combination chemotherapy for metastatic testicular cancer. J Clin Oncol 1990, 8, 21-26.
25. Bokemeyer C, Berger CC, Kuczyk MA, Schmoll H-J. Evaluation of long-term toxicity after chemotherapy for testicular cancer. J Clin Oncol 1996, 14, 2923-2932.
26. Lampe H, Horwich A, Norman A, Nicholls J, Dearnaley DP. Fertility after chemotherapy for testicular germ cell cancers. J Clin Oncol 1997, 15, 239-245.
27. Pedersen-Bjergaard J, Hansen SW, Larsen SO, Daugaard G, Philip P, Rorth M. Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin and bleomycin for germ-cell tumours. Lancet 1991, 338, 359-363.
28. Vasey PA, Dunlop DJ, Kaye SB. Primary mediastinal germ cell tumour and acute monocytic leukaemia occurring concurrently in a 15-year-old boy. Ann Oncol 1994, 5, 649-652.
29. Nichols CR, Roth BJ, Heerema N, Griep J, Tricot G. Hematologic neoplasia associated with primary mediastinal germ-cell tumors. N Engl J Med 1990, 322, 1425-1429.
30. Bajorin DF, Sarosdy MF, Pfister DG, et al. Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional study. J Clin Oncol 1993, 11, 598-606.
31. Tjulandin SA, Garin AM, Mescheryakov AA, et al. Cisplatin-etoposide and carboplatin-etoposide induction chemotherapy for good-risk patients with germ cell tumors. Ann Oncol 1993, 4, 633-637.
32. Horwich A, Sleijfer D, Fosså S, et al. On behalf of the UK Medical Research Council Testicular Tumour Working Party & EORTC Genito-Urinary Group. A trial of carboplatin-based combination chemotherapy in good prognosis metastatic testicular cancer. Proc Am Soc Clin Oncol 1994, 13, 709 (abstract).
33. Bokemeyer C, Kohrman O, Tischler J, et al. A randomized trial of cisplatin, etoposide and bleomycin (PEB) versus carboplatin, etoposide and bleomycin (CEB) for patients with 'good risk' metastatic non-seminomatous germ cell tumors. Ann Oncol 1996, 7, 1015-1021.
34. 2) in childhood non-metastatic non-seminomatous germ cell tumor (NSGCT). Experience of the SFOP. Med Pediatr Oncol 1995, SIOP XXVII, 0-47 (abstract).
35. Pinkerton CR, Broadbent V, Horwich A, et al. JEB - a carboplatin based regimen for malignant germ cell tumours in children. Br J Cancer 1990, 62, 257-262.
36. Horwich A, Dearnley DP, Nicholls J, et al. Effectiveness of carboplatin, etoposide and bleomycin combination chemotherapy in good prognosis metastatic testicular nonseminomatous germ cell tumors. J Clin Oncol 1991, 9, 62-69.
37. Mann JR, Raafat F, Robinson K, et al. The UKCCSG's germ cell tumour (GCT) studies: carboplatin, etoposide and bleomycin are as effective as and less toxic than previous regimens for malignant extracranial non-gonadal tumours. Med Pediatr Oncol 1996. SIOP XXVIII, 0-41 (abstract).
38. Newell DR, Pearson ADJ, Balmanno K, et al. Carboplatin pharmacokinetics in children: the development of a paediatric dosing formula. J Clin Oncol 1993, 11, 2314-2323.
39. Levi JA, Raghavan D, Harvey V, et al. The importance of bleomycin in combination chemotherapy for good-prognosis germ cell carcinoma. J Clin Oncol 1993, 11, 1300-1305.
40. Loehrer PJ, Johnson D, Elson P, et al. Importance of bleomycin in favorable-prognosis disseminated germ cell tumors: an Eastern Cooperative Oncology Group trial. J Clin Oncol 1995, 13, 470-476.
41. Germa JR, Sagarra AF, Izquierdo MA, Segui MA. Sequential trials of cisplatin, vinblastine and bleomycin and etoposide and cisplatin in disseminated nonseminomatous germ cell tumors of the testis with a good prognosis at a single institution. Cancer 1993, 71, 796-803.
42. Wozniak AJ, Sampson MK, Shah NT, et al. A randomized trial of cisplatin, vinblastine and bleomycin versus vinblastine, cisplatin and etoposide in the treatment of advanced germ cell tumors of the testis: a Southwest Oncology Group Study. J Clin Oncol 1991, 9, 70-76.
43. Bajorin DF, Geller NL, Weisen SF, Bosl GJ. Two-drug therapy in patients with metastatic germ cell tumors. Cancer 1991, 67, 28-32.
44. Brada M, Horwich A, Peckham MJ. Treatment of favourable-prognosis nonseminomatous testicular germ cell tumors with etoposide, cisplatin, and reduced dose of bleomycin. Cancer Treat Rep 1987, 71, 655-656.
45. Frazier AL, Grier HE, Green DM. Treatment of endodermal sinus tumor in children using a regimen that lacks bleomycin. Med Pediatr Oncol 1996, 27, 69-73.
46. Wheeler BM, Loehrer PJ, Williams SD, Einhorn LH. Ifosfamide in refractory male germ cell tumors. J Clin Oncol 1986, 4, 28-34.
47. Levi JA, Thomson D, Harvey V, et al. Effective salvage chemotherapy with etoposide, dactinomycin, and methotrexate in refractory germ cell cancer. J Clin Oncol 1990, 8, 27-32.
48. Saxman SB, Nichols CR, Einhorn LH. Salvage chemotherapy in patients with extragonadal nonseminomatous germ cell tumors: the Indiana University experience. J Clin Oncol 1994, 12, 1390-1393.
49. Culine S, Kattan J, Lhomme C, Duvillard P, et al. A phase II study of high-dose cisplatin, vinblastine, bleomycin, and etoposide (PVeBV regimen) in malignant nondysgerminomatous germ-cell tumors of the ovary. Gynecologic Oncol 1994, 54, 47-53.
50. Siegert W, Beyer J, Strohscheer I, et al. High-dose treatment with carboplatin, etoposide, and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: a phase I/II study. J Clin Oncol 1994, 12, 1223-1231.
51. Rodenhuis S, Westermann A, Holtkamp MJ, et al. Feasibility of multiple courses of high-dose cyclophosphamide thiotena, and carboplatin for breast cancer or germ cell cancer. J Clin Oncol 1996, 14, 1473-1483.